BlackRock Institutional Trust’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-149,455
Closed -$1.9M 3976
2014
Q3
$1.9M Sell
149,455
-42,531
-22% -$635K ﹤0.01% 3100
2014
Q2
$3.27M Buy
191,986
+68,382
+55% +$1.02M ﹤0.01% 2968
2014
Q1
$1.66M Buy
123,604
+2,626
+2% +$34.4K ﹤0.01% 3234
2013
Q4
$1.55M Sell
120,978
-17,336
-13% -$182K ﹤0.01% 3259
2013
Q3
$1.25M Buy
138,314
+9,768
+8% +$81K ﹤0.01% 3301
2013
Q2
$926K Buy
+128,546
New +$944K ﹤0.01% 3350

BlackRock Institutional Trust's DRTX Position: Q4 2014 in Review

BlackRock Institutional Trust sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 149,455 shares — an estimated $1.9M sold.

BlackRock Institutional Trust first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $3.27M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BlackRock Institutional Trust reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 149,455 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $1.9M.
  • BlackRock Institutional Trust first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • BlackRock Institutional Trust's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $3.27M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BlackRock Institutional Trust's 13F filing for Q4 2014, filed 9 Feb 2015.